CNR Institutional Research Information System

DE FALCO, SANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.571
NA - Nord America 1.987
EU - Europa 588
SA - Sud America 551
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 59
OC - Oceania 8
Totale 5.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.880
SG - Singapore 1.111
CN - Cina 515
BR - Brasile 425
VN - Vietnam 265
HK - Hong Kong 250
IT - Italia 200
FR - Francia 164
KR - Corea 106
BD - Bangladesh 84
JP - Giappone 53
NL - Olanda 50
DE - Germania 49
CA - Canada 42
IN - India 40
GB - Regno Unito 37
ID - Indonesia 36
AR - Argentina 28
CO - Colombia 25
EC - Ecuador 22
MX - Messico 21
FI - Finlandia 19
VE - Venezuela 16
ZA - Sudafrica 16
PY - Paraguay 14
TR - Turchia 14
IL - Israele 13
CR - Costa Rica 12
SA - Arabia Saudita 12
EG - Egitto 11
ES - Italia 11
JM - Giamaica 10
PK - Pakistan 9
RU - Federazione Russa 9
UZ - Uzbekistan 9
IQ - Iraq 8
MY - Malesia 8
AU - Australia 7
CL - Cile 7
LV - Lettonia 7
MA - Marocco 7
TT - Trinidad e Tobago 7
BO - Bolivia 5
SE - Svezia 5
TH - Thailandia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
KE - Kenya 4
MO - Macao, regione amministrativa speciale della Cina 4
PE - Perù 4
PH - Filippine 4
PL - Polonia 4
RO - Romania 4
TN - Tunisia 4
UA - Ucraina 4
AL - Albania 3
AT - Austria 3
IE - Irlanda 3
JO - Giordania 3
LT - Lituania 3
OM - Oman 3
SN - Senegal 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
KZ - Kazakistan 2
NI - Nicaragua 2
SC - Seychelles 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
Totale 5.758
Salva come PNG Salva come JPEG
Città #
Singapore 666
Santa Clara 441
Hong Kong 241
Hefei 221
San Jose 197
Ashburn 132
Lauterbourg 130
Ho Chi Minh City 112
Seoul 106
Beijing 78
Los Angeles 58
Dallas 56
Hanoi 52
New York 36
São Paulo 35
Tokyo 35
Naples 33
Buffalo 26
Frankfurt am Main 24
Rome 21
Milan 20
Marigliano 18
Chicago 17
Guangzhou 16
Atlanta 15
Aversa 15
Helsinki 15
Minamishinagawa 14
Rio de Janeiro 14
Boardman 13
Council Bluffs 13
Belo Horizonte 12
Porto Alegre 11
Avellino 10
Brooklyn 10
Da Nang 10
Toronto 10
Bengaluru 9
Curitiba 9
Dhaka 9
Düsseldorf 9
Houston 9
Miami 9
Denver 8
Haiphong 8
Kingston 8
Phoenix 8
San Francisco 8
The Bronx 8
Asunción 7
Brasília 7
Cairo 7
Charlotte 7
Goiânia 7
Hải Dương 7
Istanbul 7
Johannesburg 7
Las Vegas 7
Mexico City 7
Nuremberg 7
Riga 7
San José 7
Tashkent 7
Amsterdam 6
Baghdad 6
Baltimore 6
Biên Hòa 6
Bogotá 6
Cleveland 6
Guarulhos 6
Kuala Lumpur 6
Manchester 6
Ninh Bình 6
Orem 6
Portsmouth 6
Santiago 6
Cincinnati 5
Columbus 5
London 5
Quito 5
Shanghai 5
Shenzhen 5
Tampa 5
Boston 4
Campinas 4
Can Tho 4
Caracas 4
Chengdu 4
Fayetteville 4
Fort Worth 4
Guayaquil 4
Jakarta 4
Jeddah 4
Lappeenranta 4
Lima 4
Montevideo 4
Montreal 4
Nairobi 4
Palermo 4
Philadelphia 4
Totale 3.314
Salva come PNG Salva come JPEG
Nome #
Human IgG1 antibodies suppress angiogenesis in a target-independent manner. 237
Long Non-coding RNA T-UCstem1 Controls Progenitor Proliferation and Neurogenesis in the Postnatal Mouse Olfactory Bulb through Interaction with miR-9 108
Epigenetic control of hypoxia inducible factor-1?-dependent expression of placental growth factor in hypoxic conditions 104
Aflibercept in the treatment of diabetic macular edema: a review and consensus paper. 98
VEGFR1 signaling in retinal angiogenesis and microinflammation 86
Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization 84
Recombinant humanized Fab fragments targeting the CFC domain of human Cripto-1 81
alpha-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells 79
Small Interfering RNA Induced TLR3 Activation Inhibits Blood and Lymphatic Vessel Growth 77
Anti-neuropilin-1 peptide inhibits synoviocyte survival, angiogenesis, and experimental arthritis. 71
Placental growth factor-1 and -2 induce hyperplasia and invasiveness of primary rheumatoid synoviocytes 70
New strategies to inhibit pathological angiogenesis 68
L-Proline Induces a Mesenchymal-like Invasive Program in Embryonic Stem Cells by Remodeling H3K9 and H3K36 Methylation 68
Placental growth factor variant for inhibition of vegf-dependent angiogenesis 67
Use of a recombinant protein as receptor of a hepatitis virus 65
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 64
Suppression of Choroidal Neovascularization in PlGF -/- Mice Is Due to Elevated VEGF-A and VEGFR-1 Activation. 63
Prolyl 3-hydroxylase 2 is a molecular player of angiogenesis 63
Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression. 63
Cancer-derived exosomal Alu RNA promotes colorectal cancer progression 61
PlGF and VEGF-A/PlGF Heterodimer are Crucial for Recruitment and Activation of Immune Cells During Choroid Neovascularization 61
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 61
Generation and testing of engineered multimeric Fabs of trastuzumab 60
Identification of placenta growth factor determinants for binding and activation of Flt-1 receptor 59
Synthetic Peptide Libraries. From random mixtures to in vivo testing. 59
Combined HAT/EZH2 modulation leads to cancer-selective cell death 59
The Cellmaker: a fully automated robotic platform to identify stem cell regulators 57
Synergistic interactions of PlGF and VEGF contribute to blood-retinal barrier breakdown through canonical NFkB activation. 57
Full Functional Knockout of Placental Growth Factor by Knockin with an Inactive Variant Able to Heterodimerize with VEGF-A 56
Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications. 55
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases. 54
A placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism 54
Branched peptides for the modulation of protein-protein interactions: More arms are better than one? 53
The Cellmaker: a fully automated robotic platform to identify stem cell regulators 53
An Automated High Throughput Screening-Compatible Assay to Identify Regulators of Stem Cell Neural Differentiation. 53
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells. 52
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models 49
Intravenous immune globulin suppresses angiogenesis in mice and humans. 49
A Novel Robotic Platform for Cell Based Phenotypic Assays Reveals a Key Role of Metabolites in the Control of Embryonic Stem Cell Metastability 48
Hypoxia activates placental growth factor expression in lymphatic endothelial cells 47
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 47
Control of embryonic stem cell metastability by L-proline catabolism 47
Retinal angiogenesis suppression through small molecule activation of p53 46
Placental growth factor regulates the generation of T(H)17 cells to link angiogenesis with autoimmunity 45
Identification of Cripto inhibitors to direct cell fate specification in ES cells 44
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models 44
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models. 42
Control of embryonic stem cell metastability by L-proline catabolism. 42
The vascular endothelial growth factors and receptors family: up to now the only target for anti-angiogenesis therapy. 42
Epigenetic regulation of hypoxia-induced PlGF expression 41
Inhibition of pathological angiogenesis atagonizing VEGF Receptor 1 41
EMBO Workshop - Cell Migration, Tissue Invasion and Disease 41
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases. 40
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers 39
Ribonucleases and angiogenins from fish. 38
Propionyl-L-Carnitine Enhances Wound Healing and Counteracts Microvascular Endothelial Cell Dysfunction. 38
A SMALL SYNTHETIC CRIPTO BLOCKING PEPTIDE IMPROVES DOPAMINERGIC DIFFERENTIATION AND FUNCTIONAL INTEGRATION OF MOUSE EMBRYONIC STEM CELLS IN A RAT MODEL OF PARKINSON S DISEASE 38
A placental growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism. 38
Placental growth factor variant for inhibition of vegf-dependent angiogenesis 37
HUMAN L7A RIBOSOMAL-PROTEIN - SEQUENCE, STRUCTURAL ORGANIZATION, AND EXPRESSION OF A FUNCTIONAL GENE 37
Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia 37
Propionyl-L-carnitine improves post-ischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production 36
A placental growth factor variant unable to recognize VEGFR-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization 36
A review on the in vitro activity of phosphorothioate oligonucleotides against Human Immunodeficency Viruses in vitro. 36
Epigenetic control of hypoxia-induced Placental Growth Factor expression 36
Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells 35
Inhibition of Choroidal and Corneal Pathologic Neovascularization by Plgf1-de Gene Transfer. 34
A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization 34
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. 33
Corneal avascularity is due to soluble VEGF receptor-1 33
The Role Of Placental Growth Factor In Hypoxia Induced Angiogenesis In The Adult Mouse Lung 33
Inhibition of choroidal and corneal pathological neovascularization by Plgf-de gene transfer 32
A PROTEASES-STABLE TERAMERIC TRIPEPTIDE ABLE TO ANTAGONIZE VEGF RECEPTOR 1. 31
Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide 31
A small synthetic cripto blocking Peptide improves neuralinduction, dopaminergic differentiation, and functional integration of mouseembryonic stem cells in a rat model of Parkinson's disease 31
Antiangiogenesis therapy: an update after the first decade. 30
Plgf-/-eNos-/- mice show reduced angiogenesis and increased oxidative stress in ischemic conditions 30
PHARMACOLOGICAL TARGETING OF CRIPTO SIGNALING DIRECTS EMBRYONIC STEM CELL FATE AND IMPAIRS THEIR TUMORIGENIC POTENTIAL IN VIVO 30
Cripto Blocking molecules and therapeutic uses thereof 30
Determinants of human placental growth factor for binding and activation of Flt-1 receptor. 30
PLGF-1 induces corneal neovascularization by silencing soluble VEGFR-1 30
Age-related increase of stem marker expression influences vascular smooth muscle cell properties 30
An expression system for the single-step production of recombinant human amidated calcitonin 29
Identification of inhibitors of PlGF/ Flt-1 interaction by the screening of peptide compounds libraries 29
The Chemical Synthesis of Mouse Cripto CFC variants 29
A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease 29
N-terminal myristylation of HBV preS1 domain enhances receptor recognition 29
Role of placental growth factor and its receptor Flt-1 in rheumatoid inflammation: A link between angiogenesis and inflammation 29
Placental Growth Factor Variants for inhibition of VEGF-dependent tumor growth. 29
Identification of Cripto-Alk4 inhibitors through the screening of combinatorial peptide libraries 28
The C. elegans pvf-1 gene encodes a PDGF/VEGF-like factor able to bind mammalian VEGF receptors and to induce angiogenesis 28
Upregulation of the Hepatitis B Virus Binding protein (HBV-BP) by the preS1[21-47] sequence. 28
Cardiovascular and Neural System from Development to Disease: PlGF 28
Inhibition of pathological angiogenesis antagonizing VEGF receptor I. 28
Involvement of HIF-1alfa in hypoxia-induced Placental Growth Factor expression 27
Non-Targeted siRNA Suppress Angiogenesis in the Cornea, Dermis and Hind Limb 27
NEW INHIBITORS OF VEGF-DEPENDENT ANGIOGENESIS ASSOCIATED TO OCULAR NEOVASCULAR DISEASES. 27
Anomalous distribution of the unaffected CTG repeats allele of DM patients 27
The biflavonoid Amentoflavone inhibits neovascularization preventing the activity of pro-angiogenic vascular endothelial growth factors 27
LIPOPROTEIN-MEDIATED DELIVERY OF ANTISENSE OLIGONUCLEOTIDES 27
Totale 4.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.639
article - articoli 15.335
book - libri 120
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202447 0 0 0 0 0 0 0 0 5 1 36 5
2024/20251.978 19 14 162 75 435 121 12 83 38 75 515 429
2025/20263.009 135 292 310 467 559 81 411 153 183 172 133 113
2026/2027855 176 307 372 0 0 0 0 0 0 0 0 0
Totale 5.889